<DOC>
	<DOCNO>NCT02030912</DOCNO>
	<brief_summary>A randomised , open label study design select order determine emergence persistence antibiotic resistant bacteria human composition indigenous microbiotas various body site . These involve administration volunteer minocycline amoxicillin- control group receive placebo . Microbiology skin , saliva , faecal , skin nasal micro flora , safety adverse event , vital sign , evaluate . The objective metagenomic analysis : - To identify vivo molecular mechanism responsible antibiotic resistance transfer indigenous oral faecal microbiotas use metagenomics resistome analysis . - To determine impact use antimicrobial agent oral resistome - To determine impact use antimicrobial agent faecal resistome - To determine ecological impact use antimicrobial agent relative abundance phylotypes indigenous oral microbiota - To determine ecological impact use antimicrobial agent relative abundance phylotypes indigenous faecal microbiotas</brief_summary>
	<brief_title>Effect Minocycline &amp; Amoxicillin Antibiotic Resistant Bacteria Indigenous Microbiotas</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>1 . Men woman age 18 40 year . 2 . Following verbal &amp; write information trial , subject sign &amp; date informed consent study related activity carry . 3 . Subject legally competent able communicate effectively study personnel 4 . Normal find medical history physical examination , unless investigator considers abnormality clinically irrelevant . 5 . Male female subject use medically acceptable method contraception nonchildbearing potential ( i.e. , surgically sterilebilateral tubal ligation removal ovary and/or uterus least 6 month prior dose naturally postmenopausal least one year Screening FSH leveâ‰¥l 40 mIU/L ) . A negative serum pregnancy test require Screening female . 1 . Regular use medication , except contraceptive , vitamin tablet , treatment antimicrobial agent within 3 month precede study , Use antibiotics 4 week prior study drug application use concomitant systemic topical antibiotic , Systemic treatment immunosuppressive drug e.g . cyclosporine , azathioprine oral corticosteroid within 4 week prior baseline visit ( Visit 2 ) . 2 . Participation trial another investigational drug within 3 month precede study 3 . Present residual gastrointestinal , renal insufficiency hepatic disorder 4 . Abnormal pathology nasal passages 5 . Any clinically significant allergy drug intolerance 6 . Active hay fever , ongoing cold/flu symptom , include rhinitis baseline ( visit 2 ) 7 . Any medical history renal insufficiency hepatic disorder condition know interfere absorption , distribution , metabolism excretion drug 8. history hypersensitivity betalactams tetracycline 9. pregnant breastfeed woman 10 . Subjects know suspect able comply trial protocol ( e.g . alcoholism , drug dependency , psychological state ) . History regular alcohol consumption exceed average weekly intake alcohol great 21 unit female 28 unit male . One unit equivalent halfpint beer one measure spirit one glass wine . 11 . Subjects know suspected immunodeficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>The impact number different type antibiotic</keyword>
	<keyword>The emergence persistence antibiotic resistance</keyword>
</DOC>